RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) - Total Liabilities
Based on the latest financial reports, RHOEN-KLINIK.UNSP.ADR 1/2 (RHKU) has total liabilities worth €523.09 Million EUR (≈ $611.55 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check RHKU cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
RHOEN-KLINIK.UNSP.ADR 1/2 - Total Liabilities Trend (2021–2024)
This chart illustrates how RHOEN-KLINIK.UNSP.ADR 1/2's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see RHOEN-KLINIK.UNSP.ADR 1/2 total assets.
RHOEN-KLINIK.UNSP.ADR 1/2 Competitors by Total Liabilities
The table below lists competitors of RHOEN-KLINIK.UNSP.ADR 1/2 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Tigerair Taiwan Co. Ltd.
TW:6757
|
Taiwan | NT$20.36 Billion |
|
Carlyle Secured Lending Inc
NASDAQ:CGBD
|
USA | $1.62 Billion |
|
Pexip Holding ASA
OL:PEXIP
|
Norway | Nkr508.69 Million |
|
BIOCYTOGEN PHARMA. H YC1
F:I54
|
Germany | €1.54 Billion |
|
Shanghai Research Institute of Building Sciences Group Co. Ltd A
SHG:603153
|
China | CN¥1.77 Billion |
|
Bumi Serpong Damai Tbk
JK:BSDE
|
Indonesia | Rp25.91 Trillion |
|
MLP Group S.A.
WAR:MLG
|
Poland | zł4.42 Billion |
|
Yext Inc
NYSE:YEXT
|
USA | $473.64 Million |
Liability Composition Analysis (2021–2024)
This chart breaks down RHOEN-KLINIK.UNSP.ADR 1/2's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See RHKU equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.40 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.28 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how RHOEN-KLINIK.UNSP.ADR 1/2's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for RHOEN-KLINIK.UNSP.ADR 1/2 (2021–2024)
The table below shows the annual total liabilities of RHOEN-KLINIK.UNSP.ADR 1/2 from 2021 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €530.51 Million ≈ $620.22 Million |
+8.20% |
| 2023-12-31 | €490.30 Million ≈ $573.21 Million |
+8.11% |
| 2022-12-31 | €453.51 Million ≈ $530.20 Million |
+2.88% |
| 2021-12-31 | €440.82 Million ≈ $515.36 Million |
-- |
About RHOEN-KLINIK.UNSP.ADR 1/2
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company also operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.